alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Editorial Note on Part 73
Editorial Note: Nomenclature changes to part 73 appear at 66 FR 66742, Dec. 27, 2001.

§ 73.2327 Chromium oxide greens. ( a ) *Identity and specifications.* The color additive chromium oxide greens shall conform in identify and specifications to the requirements of § 73.1327 (a)(1) and (b).
( b ) *Uses and restrictions.* The color additive chromium oxide greens may be safely used in externally applied cosmetics, including cosmetics intended for use in the area of the eye, in amounts consistent with good manufacturing practice.
( c ) *Labeling requirements.* The color additive and any mixtures prepared therefrom intended solely or in part for coloring purposes shall bear, in addition to any information required by law, labeling in accordance with the provisions of § 70.25 of this chapter.
( d ) *Exemption from certification.* Certification of this color additive is not necessary for the protection of the public health, and therefore batches thereof are exempt from the certification pursuant to section 721(c) of the act.
[42 FR 36452, July 15, 1977]
§ 876.5665 Water purification system for hemodialysis. ( a ) *Identification.* A water purification system for hemodialysis is a device that is intended for use with a hemodialysis system and that is intended to remove organic and inorganic substances and microbial contaminants from water used to dilute dialysate concentrate to form dialysate. This generic type of device may include a water softener, sediment filter, carbon filter, and water distillation system.
( b ) *Classification.* Class II (special controls). The device, when it is a water purification subsystem disinfectant, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.
[48 FR 53023, Nov. 23, 1983, as amended at 84 FR 71814, Dec. 30, 2019]
§ 1.108-3 Intercompany losses and deductions. ( a ) *General rule.* This section applies to certain losses and deductions from the sale, exchange, or other transfer of property between corporations that are members of a consolidated group or a controlled group (an intercompany transaction). See section 267(f) (controlled groups) and § 1.1502-13 (consolidated groups) for applicable definitions. For purposes of determining the attributes to which section 108(b) applies, a loss or deduction not yet taken into account under section 267(f) or § 1.1502-13 (an intercompany loss or deduction) is treated as basis described in section 108(b) that the transferor retains in property. To the extent a loss not yet taken into account is reduced under this section, it cannot subsequently be taken into account under section 267(f) or § 1.1502-13. For example, if S and B are corporations filing a consolidated return, and S sells land with a $100 basis to B for $90 and the $10 loss is deferred under section 267(f) and § 1.1502-13, the deferred loss is treated for purposes of section 108(b) as $10 of basis that S has in land (even though S has no remaining interest in the land sold to B) and is subject to reduction under section 108(b)(2)(E). Similar principles apply, with appropriate adjustments, if S and B are members of a controlled group and S's loss is deferred only under section 267(f).
( b ) *Effective date.* This section applies with respect to discharges of indebtedness occurring on or after September 11, 1995.
[T.D. 8597, 60 FR 36680, July 18, 1995]
Editorial Note on Part 882
Editorial Note: Nomenclature changes to part 882 appear at 73 FR 35341, June 23, 2008.

§ 882.5897 External upper limb tremor stimulator. ( a ) *Identification.* An external upper limb tremor stimulator is a prescription device which is placed externally on the upper limb and designed to aid in tremor symptom relief of the upper limb.
( b ) *Classification.* Class II (special controls). The special controls for this device are: ( 1 ) Non-clinical performance testing must assess the following: ( i ) Characterization of the electrical stimulation, including the following, must be performed: Waveforms, output modes, maximum output voltage, maximum output current, pulse duration, frequency, net charge per pulse, maximum phase charge at 500 ohms, maximum current density, maximum average current, and maximum average power density.
( ii ) Impedance testing, current distribution across the electrode surface area, adhesive integrity, and shelf life testing of the electrodes and gels must be conducted.
( iii ) Simulated use testing of sensor performance and the associated algorithms that determine the stimulation output must be conducted.
( 2 ) Patient-contacting components of the device must be demonstrated to be biocompatible.
( 3 ) Performance testing must demonstrate electrical, thermal, and mechanical safety along with electromagnetic compatibility (EMC) of the device in the intended use environment.
( 4 ) Software verification, validation, and hazard analysis must be performed.
( 5 ) Physician and patient labeling must include: ( i ) Summaries of electrical stimulation parameters;
( ii ) Instructions on how to correctly use and maintain the device;
( iii ) Instructions and explanations of all user-interface components;
( iv ) Instructions on how to clean the device;
( v ) A shelf life for the electrodes and gel; and
( vi ) Reuse information.
[83 FR 52316, Oct. 17, 2018]
Incorporation by Reference 

Docket ID No. EPA-HQ-OAR-2009-0927 

January 7, 2010 

The contents of the following dockets are hereby incorporated by reference into and are 

considered to be included in, contained in and to have been placed in Docket EPA-HQ-OAR2009-0927 (Greenhouse Gas Reporting for Additional Sources of Fluorinated Gases): 

1) EPA-HQ-OAR-2008-0508 (Greenhouse Gas Mandatory Reporting) 

2) EPA-HQ-OAR-2009-0924 (Determination of Confidential Business Information) 

3) EPA-HQ-OAR-2009-0925 (Corporate Parent and NAICS Code) 

Accessing dockets: 

Publicly available docket materials are available either electronically through 

www.regulations.gov or in hard copy at EPA’s Docket Center, Public Reading Room, EPA West 

Building, Room 3334, 1301 Constitution Avenue, NW, Washington, DC 20004. This Docket 

Facility is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal holidays. 

The telephone number for the Public Reading Room is (202) 566-1744, and the telephone 

number for the Air Docket is (202) 566-1742.
Editorial Note on Part 878
Editorial Note: Nomenclature changes to part 878 appear at 73 FR 35341, June 23, 2008.

§ 878.5360 Tweezer-type epilator. ( a ) *Identification.* The tweezer-type epilator is an electrical device intended to remove hair. The energy provided at the tip of the tweezer used to remove hair may be radio frequency, galvanic (direct current), or a combination of radio frequency and galvanic energy.
( b ) *Classification.* Class I (general controls). The device is exempt from premarket notification procedures in subpart E of part 807 of this chapter subject to § 878.9.
[63 FR 57060, Oct. 26, 1998]
- USGS Home
- Contact						   USGS
- Search 
USGS

- mobile menu barsUSGS Publications Warehouse
    Contact
    Explore recent 
    publications by USGS Authors
    Browse all of Pubs 
    Warehouse by Publication type and year
    FAQS
    Web 
    Service Documentation
    Other 
    Resources
    Descriptions of US Geological Survey Report Series
- USGS Publications Warehouse
- Contact
- Explore recent 
    publications by USGS Authors
- Browse all of Pubs 
    Warehouse by Publication type and year
- FAQS
- Web 
    Service Documentation
- Other 
    Resources
- Descriptions of US Geological Survey Report Series

- USGS Publications 
  Warehouse
- Explore					    
  Explore recent 
    publications by USGS Authors
    Browse all of Pubs 
    Warehouse by Publication type and year
- Explore recent 
    publications by USGS Authors
- Browse all of Pubs 
    Warehouse by Publication type and year
- Documentation					    
  FAQS
    Web 
    Service Documentation
    Other 
    Resources
    Descriptions of US Geological Survey Report Series
- FAQS
- Web 
    Service Documentation
- Other 
    Resources
- Descriptions of US Geological Survey Report Series
- Contact

### Fluvial monazite deposits in the southeastern United States, 
with a section on mineral analyses

#### Professional Paper 568

Tweet


#### Links

- More information: **National Geologic Map Database Index Page**     
                             (html)
- Document: **Document**                                
  (pdf)
- Plates:
- **Plate 1**                                
    (pdf)
- **Plate 2**                                
    (pdf)
- **Plate 3**                                
    (pdf)
- **Plate 4**                                
    (pdf)
- **Plate 5**                                
    (pdf)
- **Plate 6**                                
    (pdf)
- **Plate 7**                                
    (pdf)
- **Plate 8**                                
    (pdf)
- **Plate 9**                                
    (pdf)
- Paper 
  version: **USGS Store**
- Download citation as:  RIS

#### Abstract

#### Additional publication details

Part or all of this report is presented in Portable 
Document Format (PDF). For best results viewing and printing PDF documents, it 
is recommended that you download the documents to your computer and open them 
with Adobe Reader. PDF documents opened from your browser may not display or 
print as intended. Download the latest version of Adobe 
Reader, free of charge. More information about viewing, downloading, and 
printing report files can be found here.

Accessibility
				    FOIA				    Privacy				    Policies and 
Notices

U.S. Department of the Interior				    | 				    
U.S. Geological 
Survey				    				   URL: http://pubs.er.usgs.gov/publication/pp568 
                   				    				   Page Contact Information: Pubs 
Warehouse Contact Page				    				   Page Last Modified: February 02, 
2012 00:05:44
I 

118TH CONGRESS 

2D SESSION H. R. 8033 

To amend title 5, United States Code, to clarify the information required 

to be included in a certification by an agency that a rule will not 

have a significant economic impact on a substantial number of small 

entities. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 17, 2024 

Mr. LUETKEMEYER (for himself, Mr. MEUSER, Mr. MANN, and Ms. SALAZAR) 

introduced the following bill; which was referred to the Committee on the 

Judiciary, and in addition to the Committee on Small Business, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To amend title 5, United States Code, to clarify the information required to be included in a certification by an 

agency that a rule will not have a significant economic 

impact on a substantial number of small entities. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Regulatory Trans5 parency for Small Businesses Act’’. 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 8033 IH

1 SEC. 2. INFORMATION REQUIRED TO BE INCLUDED IN A 

2 CERTIFICATION BY AN AGENCY THAT A RULE 

3 WILL NOT HAVE A SIGNIFICANT ECONOMIC 

4 IMPACT ON A SUBSTANTIAL NUMBER OF 

5 SMALL ENTITIES. 

6 Section 605 of title 5, United States Code, is amend7 ed by adding at the end the following: 

8 ‘‘(d) The certification under subsection (b) shall in9 clude, at a minimum, the following: 

10 ‘‘(1) The approximate number of small entities, 

11 if any, impacted by the rule, and an identification of 

12 any such small entity (including the North American 

13 Industry Classification System code, if applicable). 

14 ‘‘(2) An estimate of the total cost of imple15 menting the rule, including the cost of compliance 

16 with the rule, which may be measured as an esti17 mated percentage of the revenue of the small entities 

18 determined to be impacted under paragraph (1), or 

19 another reasonable measure of economic signifi20 cance. 

21 ‘‘(3) A determination of whether the costs of 

22 compliance under paragraph (2) represent a signifi23 cant economic impact, and the criteria used to make 

24 such determination. 

25 ‘‘(4) A determination of the number of small 

26 entities that will experience a significant economic 


ssavage on LAPJG3WLY3PROD with BILLS
3 

•HR 8033 IH

1 impact as a result of the rule, whether that number 

2 is substantial, and the criteria used to make such 

3 determinations.’’. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS
EXHIBIT
        32.1
 
 CERTIFICATION
        PURSUANT TO
 18
        U.S.C.
        SECTION 1350,
 AS
        ADOPTED PURSUANT TO
 SECTION
        906 OF THE SARBANES-OXLEY ACT OF 2002
  In
        connection with the Quarterly Report of Fonix Corporation on Form 10-Q for
        the
        period ending September 30, 2006, as filed with the Securities and Exchange
        Commission on the date hereof (the "Report"), I, Thomas A. Murdock, Chief
        Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section
        1350,
        as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
        that:
 
 (1)  The
        Report fully complies with the requirements of section 13(a) or 15(d) of
        the
        Securities Exchange Act of 1934; and
 
 (2)  The
        information contained in the Report fairly presents, in all material respects,
        the financial condition and results of operations of the Company.
   
 **/s/
                  THOMAS A.
                  MURDOCK**Thomas
                  A. MurdockChief
                  Executive Officer
 Dated
        November 20, 2006
#### § 1.1402(a)-18 Split-dollar life insurance arrangements.

*See* §§ 1.61-22 and 1.7872-15 for rules relating to the treatment of split-dollar life insurance arrangements.

[T.D. 9092, 68 FR 54352, Sept. 17, 2003]
Editorial Note on Part 890
Editorial Note: Nomenclature changes to part 890 appear at 73 FR 35341, June 23, 2008.

§ 890.3050 External compression device for internal jugular vein compression. ( a ) *Identification.* An external compression device for internal jugular vein compression is a non-invasive device that is intended to increase intracranial blood volume to reduce the occurrence of specific changes in the brain following head impacts sustained from the environment of use.
( b ) *Classification.* Class II (special controls). The special controls for this device are: ( 1 ) The patient-contacting components of the device must be demonstrated to be biocompatible.
( 2 ) Performance testing must demonstrate that the device performs as intended under anticipated conditions of use for the duration of the labeled use life.
( 3 ) Human factors and usability testing must demonstrate that users can correctly use the device, including the user's ability to correctly determine device size and confirm the proper fit of the device. Users must understand product limitations, warnings, and precautions, including the warning that the device does not prevent head injury and medical treatment should be sought following head injury.
( 4 ) Labeling must include the following: ( i ) A warning that the device does not replace, and should be worn with, other protective sports equipment associated with specific sports activities, such as helmets and shoulder pads;
( ii ) A warning that the device should not be worn if it interferes with other existing protective equipment;
( iii ) A warning that users should avoid head and neck impacts to the extent possible;
( iv ) A warning that serious harm can result from persistent, excessive pressure on the neck due to incorrect device size and fit; and
( v ) A warning that the device has not been demonstrated to prevent long-term cognitive function deficits, and the ultimate impact on clinical outcomes has not been evaluated.
[89 FR 71160, Sept. 3, 2024]
#### H. E. McCONNELL & SON, et al *v.*Frances SADLE

5-5339

455 S. W. 2d 880

Opinion delivered June 29, 1970

*Cockrill, Laser, McGehee, Sharp ir Boswell,*for appellants.

*John Purtle,*for appellee.

Carleton Harris, Chief Justice.

This is a workmen’s compensation case, being an appeal from a judgment of the Pulaski County Circuit Court, in which that court affirmed an order rendered by the commission in favor of claimant, Mrs. Frances Sadie. However, only one issue was passed upon, and the order is not reviewable because it does not constitute a final order. Mrs. Sadie filed a claim for dependency benefits alleging that she was the widow of Lou M. Sadie, who allegedly died as a result of an accidental injury in the course of his employment with H. E. McConnell & Son on February 5, 1967. The claim is controverted in its entirety by the McConnell company and its insurance carrier. However, the only question passed upon by the referee and the full commission was whether Mrs. *1183Sadie was the legal widow and dependent of Lou Sadie. The commission found for claimant, but held in abeyance the question of whether decedent’s death arose out of and during the course of his employment. Thus, an adjudication of the one issue presented would not determine whether the claim should be allowed.

While no objections to the determination of this one phase of the litigation are raised by the parties, as pointed out in *Worth Insurance Company*v. *Mrs. Tommy Patching and Helena National Bank,*241 Ark. 620, 410 S. W. 2nd 125, the want of a final order is a matter that we raise ourselves, and under Ark. Stat. Ann. § 27-2101 (Repl. 1962), we are limited to a review of final judgments and decrees. As pointed out in *Piercy*v. *Baldwin,*205 Ark. 413, 168 S. W. 2d 1110, a judgment, to be final, must dismiss the parties from the court, discharge them from the action, or conclude their rights to the subject-matter in controversy. In the case before us, only one facet of the litigation has been determined. There is left for further determination the question of whether Sadie’s death arose out of and during the course of his employment, and accordingly whether Mrs. Sadie is entitled to benefits, and if so, the amount of benefits.

In *McPherson*v. *Consolidated Casualty Company,*105 Ark. 324, 151 S. W. 283 (1912), we said:

“Cases can not be tried by piecemeal, and one can not delay the final adjudication of a cause by appealing from the separate orders of the court as the cause progresses. When a final order or judgment has been entered in the court below determining the relative rights and liabilities of the respective parties, an appeal may be taken, but not before***.”

It follows, from what has been said, that the case should be, and is, remanded to the Pulaski County Circuit Court (Third Division) with directions to re*1184mand same to the Workmen’s Compensation Commission for further development.

It is so ordered.

For good cause, we direct the issuance of an immediate mandate.
§ 1.1242-1 Losses on small business investment company stock. ( a ) *In general.* Any taxpayer who sustains a loss for a taxable year beginning after September 2, 1958, as a result of the worthlessness, or from the sale or exchange, of the stock of a small business investment company (whether or not such stock was originally issued to such taxpayer) shall treat such loss as a loss from the sale or exchange of property which is not a capital asset, if at the time of such loss: ( 1 ) The company which issued the stock is licensed to operate as a small business investment company pursuant to regulations promulgated by the Small Business Administration (13 CFR part 107), and
( 2 ) Such loss would, but for the provisions of section 1242, be a loss from the sale or exchange of a capital asset.
( b ) *Treatment of losses for purposes of section 172.* For the purposes of section 172 (relating to the net operating loss deduction), any amount of loss treated by reason of section 1242 as a loss from the sale or exchange of property which is not a capital asset shall be treated as attributable to the trade or business of the taxpayer. Accordingly, the limitation of section 172(d)(4) on the allowance of nonbusiness deductions in computing a net operating loss shall not apply to any loss with respect to the stock of a small business investment company as described in paragraph (a) of this section. See section 172(d) and § 1.172-3.
( c ) *Statement to be filed with return.* A taxpayer claiming a deduction for a loss on the stock of a small business investment company shall file with his income tax return a statement containing: The name and address of the small business investment company which issued the stock, the number of shares, basis, and selling price of the stock with respect to which the loss is claimed, the respective dates of purchase and sale of such stock, or the reason for its worthlessness and approximate date thereof. For the rules applicable in determining the worthlessness of securities, see section 165 and the regulations thereunder.
[T.D. 6500, 25 FR 12022, Nov. 26, 1960]
Editorial Note on Part 880
Editorial Note: Nomenclature changes to part 880 appear at 73 FR 35341, June 23, 2008.

§ 880.6980 Vein stabilizer. ( a ) *Identification.* A vein stabilizer is a device consisting of a flat piece of plastic with two noninvasive prongs. The device is placed on the skin so that the prongs are on either side of a vein and hold it stable while a hypodermic needle is inserted into the vein.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 880.9. If the device is not labeled or otherwise represented as sterile, it is also exempt from the current good manufacturing practice requirements of the quality system regulation in part 820 of this chapter, with the exception of § 820.180, with respect to general requirements concerning records, and § 820.198, with respect to complaint files.
[45 FR 69682, Oct. 21, 1980, as amended at 66 FR 38807, July 25, 2001]
(logo)Rialto 

         CAPITAL

 

 

**2017 AnnualStatement of Servicer Compliance (Item 1123)**

 

Poolingand Servicing Agreement (the “Pooling and Servicing Agreement”) dated as ofApril 1, 2015  by and among Wells Fargo Commercial Mortgage Securities, Inc.,as Depositor, Wells Fargo Bank, National Association as Master Servicer, RialtoCapital Advisors, LLC as Special Servicer, TriMont Real Estate Advisors, Inc.as Trust Advisor, Wells Fargo Bank, National Association as CertificateAdministrator, as Tax Administrator and as Custodian, and Wilmington Trust,National Association as Trustee relating to the Wells Fargo Commercial MortgageTrust 2015-NXS1, Commercial Mortgage Pass-Through Certificates, Series2015-NXS1

**(WFCM2015-NXS1)**

 

Theundersigned, a duly authorized officer of Rialto Capital Advisors, LLC, asspecial servicer (the “Special Servicer”) herein certifies to the following:

 

1.       Allservicing activities and performance of such servicing activities under thePooling and Servicing Agreement are performed on behalf of the SpecialServicer.

 

2.       Areview of the servicing activities and performance by the Special Servicer forthe period of January 1, 2017 to December 31, 2017 (the “Reporting Period”) inaccordance with the Pooling and Servicing Agreement has been conducted under mysupervision.

 

3.       To thebest of my knowledge, based on such review, the Special Servicer has fulfilledall of its obligations under the terms of the Pooling and Servicing Agreement,in all material respects for the Reporting Period and if there has been afailure to fulfill any such obligations in any material respect, each failureand the nature and status thereof has been specifically identifiedherein. 

 

 

Certifiedby: /s/ Adam Singer

AdamSinger, Managing Director 

 

Date:March 1, 2018